Conatus Pharmaceuticals (CNAT) IPO Opens Flat, Then Sells-Off

July 25, 2013 3:47 PM EDT Send to a Friend
The IPO for Conatus Pharmaceuticals (NASDAQ: CNAT) opened for trading at $11.06 Thursday after pricing 6,000,000 shares at $11 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login